undamentalytics Newsletter
Sign in

Neuphoria Therapeutics Inc. revenue

Neuphoria Therapeutics Inc.'s revenue was $1.2m in fiscal 2026, down 92.5% on the year before.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2025Jun 20252026Jun 2026
Revenue161
Growth on the year before—−92.5%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Neuphoria Therapeutics Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Neuphoria Therapeutics Inc.